Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms in Men

The diagnosis and treatment of benign prostatic hyperplasia (BPH) is considered to be one of the most important topics in urology and afflicts millions of older men world-wide. Although it is not life threatening, its clinical manifestation as lower urinary tract symptoms (LUTS) reduces the patient's quality of life over many years. Patients often suffer from LUTS due to BPH for a long time. If left untreated, the patients are at significant risk of potentially severe complications.

Over the last decade, new diagnostic approaches and treatment options such as prostate lasers have become more accepted in the urological community. This pocketbook provides an update of several aspects related with BPH / LUTS and covers the entire background, diagnostic process and treatment options available to patients suffering from LUTS due to BPH. It will give trainees in urology and general physicians a quick, concise but complete overview of diagnostic processes and recommended treatment options.

Prof. Dr. Alexander Bachmann was born in 1968 in Leipzig, Germany and earned his medical degree at Leipzig University Medical School in 1994. After residency in St. Gallen, Cologne, Zurich, Gelsenkirchen and Leverkusen he became a specialist in urology in 2002. Since April 2006 he has been the Head and Chairman of the Department of Urology Basel - Liestal, University Hospital Basel.

Dr Bachmann specializes in the field of ablative and reconstructive laparoscopy including donor nephrectomy and is a founding member if the International Greenlight user group (IGLU). He is member of the European Association of Urology (EAU) and has written numerous peer-reviewed publications in high-ranked Journals, including European Urology, Journal of Urology, Transplantation and World Journal of Urology.

Dr de la Rosette is Professor and Chairman of the Department of Urology, at AMC University Hospital in Amsterdam, the Netherlands. He completed his medical degree and urology residency at St Radboud University Hospital in Nijmegen, the Netherlands. He was subsequently appointed consultant urologist and Director of Minimal Invasive Urology at the Department of Urology at the St Radboud University Hospital in Nijmegen. Dr de la Rosette is the chairman of the committee on Minimal Invasive Treatment of Benign Prostatic Hyperplasia (BPH) of the International Consultation on BPH. He is also chairman of the committee on Renal Stone Disease of the International Consultation on Stone Diseases. Both consultations are patronised by the World Health Organisation (WHO). Dr de la Rosette has written over 300 peer reviewed publications and has authored many book chapters.